Innate pharma to hold its annual general meeting of shareholders on june 28, 2013, in Marseille, France

Innate Pharma (Euronext Paris: FR0010331421 – IPH) will hold its Annual General Meeting of Shareholders (“AGM”) on June 28, 2013, at 9:30 am in its headquarters, 117 avenue de Luminy, F-13009 Marseille.

The Notice of Meeting of this AGM was published on May 24, 2013 in the French official legal bulletin (“BALO”). The documentation regarding this AGM is made available to shareholders in accordance with existing regulations and at the following link.

Precision regarding the AGM:

Only shareholders having registered their shares at least three business days prior to the date of the AGM, by midnight Paris time, will be able to attend.

Shareholders holding “au porteur” (bearer) shares will need to obtain an “attestation de participation” (certificate of shareholding) from their brokers. This “attestation de participation” must be attached to the proxy form or to the appropriate voting form if shareholders wish to designate a proxy or vote by mail. The “attestation de participation” may replace the admission card for shareholders wishing to attend the AGM in person.

Written questions from shareholders must be received from the day of the publication of the official Notice of Meeting of the AGM up until four business days prior to the AGM:

• by registered letter, addressed to Innate Pharma, Shareholders Services, 117 avenue de Luminy, BP 30191, F-13009 Marseille, France or
• by e-mail to investors@innate-pharma.com.

Shareholders may obtain the legal documentation in preparation of the AGM (as described in article R. 225-83 of the French “Code de Commerce”) by sending a request by regular mail or e-mail to the above mentioned addresses.